name,smiles,stress_type,reagent,severity,temp_bin,duration_bin,strength_bin,temperature_mean,duration_mean,strength_mean,pH_mean,initial_api_percent,initial_degradant_percent,true_api_loss_percent,true_degradant_percent,model_predicted_api_loss_percent,model_predicted_degradant_percent,avg_mass,logP,logS,PSA,HBD,HBA,rot_bonds,rings,pKa_acid,pKa_base
Nitric Oxide,[N]=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,11.0,5.5,7.01,2.92,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,5.0,12.02,5.09,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.5,5.39,2.21,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.0,5.71,2.37,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,15.0,6.0,12.2,5.18,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Oxyphencyclimine,CN1CCCN=C1COC(=O)C(O)(C1CCCCC1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,4.5,15.78,6.74,344.4479,2.62,-3.8,62.13,1.0,4.0,6.0,3.0,11.54,9.27
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,2.0,1.0,5.9,2.45,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,3.0,0.8,3.23,1.27,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.0,7.23,3.02,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,4.0,6.93,2.89,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,5.0,2.5,6.14,2.55,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.0,1.5,5.22,2.17,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,2.22,0.94,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.5,2.0,7.72,3.23,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.5,5.94,2.46,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,4.5,14.14,6.02,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.2,2.52,1.05,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,3.0,7.55,3.15,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,2.01,0.84,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,8.0,3.5,5.79,2.4,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Allopurinol,OC1=NC=NC2=C1C=NN2,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,13.03,5.55,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,4.0,13.96,5.94,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,14.0,4.0,12.44,5.27,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.7,1.54,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,2.93,1.19,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.5,4.2,9.26,3.9,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.5,0.9,2.69,1.13,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,11.47,4.86,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.5,7.23,3.01,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,10.67,4.51,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.5,3.61,1.5,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,4.0,9.67,4.08,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,15.0,7.5,12.05,5.11,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,3.5,9.82,4.13,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,12.0,5.0,9.21,3.86,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Nitric Oxide,[N]=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,15.0,7.0,3.74,1.55,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.42,1.42,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,4.0,11.32,4.79,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,6.0,16.03,6.84,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,2.0,0.8,2.82,1.11,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.34,1.8,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,1.5,5.26,2.18,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,6.26,2.6,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,6.97,2.92,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,14.0,4.5,16.13,6.89,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.0,3.0,5.11,2.12,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,2.5,5.51,2.29,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.01,1.66,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.41,2.24,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,3.0,8.1,3.4,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Nitric Oxide,[N]=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,13.0,6.5,8.44,3.53,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,2.12,0.89,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,5.0,2.0,3.71,1.54,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,5.0,11.0,4.66,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,1.69,0.69,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Dexrazoxane,C[C@@H](CN1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,9.0,3.5,9.31,3.91,268.2691,-2.7,-1.4,98.82,2.0,6.0,3.0,2.0,11.2,3.2
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,7.0,2.93,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Thiethylperazine,CCSC1=CC2=C(SC3=CC=CC=C3N2CCCN2CCN(C)CC2)C=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,2.5,7.42,3.07,399.616,4.66,-4.9,9.72,0.0,3.0,6.0,4.0,,8.0
Leucine,CC(C)C[C@H](N)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,3.0,1.0,4.21,1.75,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,3.0,8.27,3.47,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Mephenytoin,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,5.0,12.31,5.22,218.2518,1.67,-2.4,49.41,1.0,2.0,2.0,2.0,11.09,-8.1
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.29,2.19,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,2.96,1.24,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,17.0,7.0,14.0,5.95,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,2.0,4.94,2.03,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Carmustine,ClCCNC(=O)N(CCCl)N=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.5,6.93,2.89,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.37,1.0,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.5,5.38,2.23,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,6.0,11.65,4.94,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.7,1.83,0.76,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,1.5,5.44,2.26,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.0,3.67,1.52,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,1.0,4.57,1.9,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,9.0,4.5,14.16,6.02,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,1.8,5.39,2.24,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,15.91,6.78,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Carmustine,ClCCNC(=O)N(CCCl)N=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,17.0,6.0,11.84,5.01,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.0,3.0,5.1,2.12,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.5,2.23,0.94,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.59,1.9,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Tranexamic acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,0.8,2.58,1.08,157.2102,-1.6,-0.94,63.32,2.0,3.0,2.0,1.0,4.56,10.22
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,2.0,7.3,3.05,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Asparagine,N[C@@H](CC(N)=O)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,2.0,0.8,4.74,1.96,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,5.0,13.26,5.63,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.0,7.16,2.99,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Gadoteridol,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.58,1.9,558.68,-6.8,-1.8,153.58,1.0,11.0,8.0,1.0,1.46,8.3
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,7.0,3.0,5.33,2.21,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.0,7.35,3.07,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,3.0,1.5,5.14,2.13,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,10.0,4.0,8.54,3.59,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,6.0,11.38,4.8,429.12,5.84,-5.4,39.41,0.0,3.0,6.0,3.0,,6.74
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,1.0,5.72,2.37,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Levocarnitine,C[N+](C)(C)C[C@H](O)CC([O-])=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,2.5,6.54,2.71,161.1989,-4.9,-1.6,60.36,1.0,3.0,4.0,0.0,4.2,-3.6
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,6.58,2.74,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,5.0,8.52,3.57,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Carmustine,ClCCNC(=O)N(CCCl)N=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.84,1.19,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,11.86,5.03,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Pyrazinamide,NC(=O)C1=NC=CN=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.5,2.2,4.92,2.04,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.5,1.7,3.28,1.36,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.21,2.16,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.5,5.65,2.35,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,1.5,5.54,2.27,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,13.0,5.0,9.21,3.87,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Mephenytoin,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.5,0.6,2.35,0.99,218.2518,1.67,-2.4,49.41,1.0,2.0,2.0,2.0,11.09,-8.1
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.97,2.48,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.16,2.14,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.5,2.0,7.08,2.96,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,2.0,5.62,2.33,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.8,2.29,0.97,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,16.0,6.0,12.11,5.13,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
L-Glutamine,N[C@@H](CCC(N)=O)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,7.79,3.25,146.1445,-4.0,-0.17,106.41,3.0,4.0,4.0,0.0,2.15,9.31
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,2.5,5.34,2.22,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,20.0,9.0,15.85,6.77,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,2.18,0.93,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Dydrogesterone,[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@]1([H])[C@@]2([H])C=CC2=CC(=O)CC[C@@]12C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,3.5,7.45,3.11,312.4458,3.79,-4.8,34.14,0.0,2.0,1.0,4.0,19.4,-4.8
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,7.37,3.08,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Lymecycline,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,5.0,14.12,6.01,602.6328,-7.1,-2.7,242.98,9.0,13.0,10.0,4.0,2.51,9.77
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.5,3.69,1.53,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,2.24,0.95,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Asparagine,N[C@@H](CC(N)=O)C(O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,2.0,0.7,5.42,2.25,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.8,2.06,0.87,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,14.0,7.0,13.53,5.75,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,6.28,2.61,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,6.05,2.52,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,4.5,8.33,3.49,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.5,6.73,2.8,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,7.0,2.5,8.31,3.48,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,10.58,4.46,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Ipratropium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(CO)C1=CC=CC=C1)[N+]2(C)C(C)C,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,3.0,1.0,4.38,1.78,332.463,-1.8,-5.5,46.53,1.0,2.0,6.0,3.0,15.15,-2.7
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,1.0,2.12,0.9,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.75,1.15,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,3.57,1.48,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,4.0,12.22,5.17,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,10.0,4.0,8.97,3.77,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.31,2.2,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,4.5,12.4,5.26,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,1.7,3.61,1.46,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.5,3.49,1.45,204.3098,-0.059,,64.52,4.0,4.0,9.0,0.0,14.82,9.55
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,2.0,0.5,2.21,0.87,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Fluorouracil,FC1=CNC(=O)NC1=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,6.0,3.0,5.93,2.46,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,2.0,6.94,2.89,226.2722,1.89,-2.4,75.27,2.0,3.0,4.0,1.0,7.48,
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,2.0,1.0,3.05,1.25,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Zafirlukast,COC1=CC(=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2)C(=O)NS(=O)(=O)C1=CC=CC=C1C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.34,1.39,575.675,6.4,-5.8,115.73,2.0,6.0,8.0,5.0,4.29,-1.1
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,4.0,2.0,6.93,2.9,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,3.0,5.04,2.09,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,15.0,7.5,11.84,5.02,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,8.0,3.0,7.07,2.94,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Leucine,CC(C)C[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,6.0,2.0,6.47,2.69,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,3.0,9.34,3.92,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,5.0,14.08,5.99,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,6.0,16.22,6.92,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.0,1.2,5.17,2.15,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,2.0,1.0,4.3,1.74,429.12,5.84,-5.4,39.41,0.0,3.0,6.0,3.0,,6.74
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,3.0,6.83,2.85,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,3.0,1.0,5.11,2.12,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,14.0,7.0,12.37,5.25,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.5,7.18,2.99,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.5,2.11,0.89,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,2.5,7.53,3.14,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Fluorouracil,FC1=CNC(=O)NC1=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,6.0,9.99,4.23,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,3.0,11.65,4.94,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,7.14,2.98,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Lymecycline,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,6.0,16.2,6.91,602.6328,-7.1,-2.7,242.98,9.0,13.0,10.0,4.0,2.51,9.77
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,5.0,1.0,5.18,2.15,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,12.0,6.0,7.84,3.28,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Indecainide,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.5,3.46,1.44,308.4174,3.26,-5.5,55.12,2.0,2.0,6.0,3.0,16.51,10.4
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.46,1.44,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,12.05,5.11,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Betamethasone,[H][C@@]12C[C@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.8,2.22,0.94,392.4611,1.68,-3.9,94.83,3.0,5.0,2.0,4.0,12.42,-3.3
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.4,1.82,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,7.0,3.5,5.04,2.09,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.0,5.81,2.41,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.05,2.09,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.27,1.77,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,11.0,5.0,8.44,3.55,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Carmustine,ClCCNC(=O)N(CCCl)N=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,9.0,3.0,8.16,3.41,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.5,0.5,2.26,0.96,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.3,2.2,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.5,7.18,3.0,418.4403,2.54,-4.5,117.0,1.0,6.0,10.0,2.0,16.96,-4.1
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.5,6.75,2.81,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,13.0,5.5,11.27,4.79,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Carmustine,ClCCNC(=O)N(CCCl)N=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,8.0,2.5,5.96,2.47,214.05,1.02,-2.2,61.77,1.0,2.0,5.0,0.0,13.36,-5.3
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.2,0.92,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.17,1.32,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,0.8,2.95,1.23,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.26,1.35,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Fluorouracil,FC1=CNC(=O)NC1=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,1.0,1.65,0.7,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.91,1.22,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.5,3.3,7.09,2.96,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,5.0,1.8,6.52,2.73,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.0,5.14,2.13,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.33,0.98,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.0,1.8,7.2,3.0,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Nitisinone,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,12.0,4.5,9.3,3.91,329.2281,3.13,-4.6,94.35,0.0,5.0,4.0,2.0,7.44,-7.3
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.25,1.36,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.0,5.53,2.29,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.6,1.5,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,2.5,7.27,3.03,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.0,7.15,2.98,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,2.0,0.7,2.38,1.0,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,12.0,5.0,11.82,5.02,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.42,1.43,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,11.02,4.68,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,0.8,2.31,0.97,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.62,1.91,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,3.0,8.75,3.67,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Lysine,NCCCC[C@H](N)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.38,1.41,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Cinnarizine,C(\C=C\C1=CC=CC=C1)N1CCN(CC1)C(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,18.0,7.0,12.98,5.52,368.524,5.88,,6.48,0.0,2.0,6.0,4.0,,8.1
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.5,6.86,2.86,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.5,3.46,1.44,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,4.0,2.0,5.27,2.19,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.0,3.0,6.16,2.55,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Allopurinol,OC1=NC=NC2=C1C=NN2,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.0,3.62,1.48,136.1115,0.031,-0.79,74.69,2.0,4.0,0.0,2.0,8.47,1.25
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,11.14,4.72,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,18.0,9.0,13.15,5.59,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.84,0.77,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,0.8,3.38,1.41,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.4,1.02,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.29,1.37,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,16.0,5.0,12.16,5.16,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.0,14.83,6.33,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.0,5.64,2.31,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,6.0,1.5,5.01,2.02,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Mazindol,OC1(N2CCN=C2C2=CC=CC=C12)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,2.5,5.29,2.18,284.74,3.44,-3.3,35.83,1.0,3.0,1.0,4.0,11.61,3.86
Reboxetine,[H][C@@]1(CNCCO1)[C@H](OC1=CC=CC=C1OCC)C1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,11.63,4.94,313.397,3.28,-4.2,39.72,1.0,4.0,6.0,3.0,,7.91
Ornithine,NCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,2.96,1.24,132.161,-3.7,0.11,89.34,3.0,4.0,4.0,0.0,2.67,10.29
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,3.03,1.27,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Benzatropine,[H][C@]12CC[C@]([H])(C[C@@]([H])(C1)OC(C1=CC=CC=C1)C1=CC=CC=C1)N2C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.78,2.4,307.4293,4.19,-5.4,12.47,0.0,2.0,4.0,4.0,,9.54
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,2.87,1.19,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.0,3.51,1.46,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.0,5.84,2.43,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,12.0,6.0,12.07,5.11,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,2.5,6.23,2.59,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,0.8,2.39,1.01,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Leucine,CC(C)C[C@H](N)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.0,0.5,1.92,0.82,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,5.0,2.5,6.3,2.62,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.5,2.34,0.99,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,3.0,7.18,3.0,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,2.0,4.41,1.82,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,4.0,1.5,5.02,2.09,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Indecainide,CC(C)NCCCC1(C(N)=O)C2=CC=CC=C2C2=CC=CC=C12,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,2.0,0.8,2.09,0.88,308.4174,3.26,-5.5,55.12,2.0,2.0,6.0,3.0,16.51,10.4
Fluticasone propionate,[H][C@@]12C[C@@H](C)[C@](OC(=O)CC)(C(=O)SCF)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])C[C@H](F)C2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,3.0,6.16,2.56,500.571,3.72,-4.6,80.67,1.0,4.0,6.0,4.0,13.61,-3.4
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,2.61,1.08,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Pyrazinamide,NC(=O)C1=NC=CN=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,3.5,8.85,3.72,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,2.5,5.85,2.43,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,9.0,3.5,12.04,5.1,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,5.0,2.0,6.87,2.87,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Lorazepam,OC1N=C(C2=CC=CC=C2Cl)C2=C(NC1=O)C=CC(Cl)=C2,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,3.0,1.0,5.17,2.13,321.158,3.53,-4.3,61.69,2.0,3.0,1.0,3.0,10.61,-2.2
Lysine,NCCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,6.0,2.0,8.35,3.5,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.5,4.88,2.02,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.38,2.23,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,3.0,1.5,4.35,1.8,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Carbidopa,C[C@@](CC1=CC(O)=C(O)C=C1)(NN)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,7.0,2.5,5.22,2.17,226.2292,-1.2,-1.8,115.81,5.0,6.0,4.0,1.0,2.35,5.66
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,0.8,2.72,1.14,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Leucine,CC(C)C[C@H](N)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,2.0,1.0,3.08,1.28,131.1729,-1.6,-0.27,63.32,2.0,3.0,3.0,0.0,2.79,9.52
Ornithine,NCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.69,1.54,132.161,-3.7,0.11,89.34,3.0,4.0,4.0,0.0,2.67,10.29
Gadoteridol,[Gd+3].CC(O)CN1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,6.0,2.0,5.66,2.35,558.68,-6.8,-1.8,153.58,1.0,11.0,8.0,1.0,1.46,8.3
Tranexamic acid,NC[C@H]1CC[C@@H](CC1)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,5.0,2.0,6.5,2.71,157.2102,-1.6,-0.94,63.32,2.0,3.0,2.0,1.0,4.56,10.22
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,7.0,3.0,8.37,3.52,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.5,4.1,1.66,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,10.0,4.5,8.57,3.6,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Acarbose,[H]C(=O)[C@H](O)[C@@H](O)[C@]([H])(O[C@@]1([H])O[C@H](CO)[C@@]([H])(O[C@H]2O[C@H](C)[C@@H](N[C@@]3([H])C=C(CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)CO,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.5,5.44,2.26,645.608,-8.3,-0.78,329.01,14.0,19.0,13.0,3.0,11.83,7.03
Biotin,[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.31,1.38,244.311,0.32,-2.3,78.43,3.0,3.0,5.0,2.0,4.4,-1.9
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.27,0.95,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,15.0,8.0,12.23,5.19,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.5,3.52,1.47,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,18.0,7.0,13.58,5.78,339.4745,3.47,-3.8,59.22,1.0,3.0,8.0,2.0,16.19,10.42
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.34,1.39,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.0,3.35,1.39,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.0,5.43,2.26,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C(S1)[N+]([O-])=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.24,1.35,307.282,2.12,-4.6,111.43,1.0,5.0,5.0,2.0,10.62,-4.2
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,2.79,1.17,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,3.0,1.0,4.85,1.98,319.872,3.93,-4.3,28.16,1.0,3.0,8.0,2.0,,10.32
Lysine,NCCCC[C@H](N)C(O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,6.93,2.89,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Fenoprofen,CC(C(O)=O)C1=CC(OC2=CC=CC=C2)=CC=C1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,17.0,8.0,12.04,5.11,242.2699,3.65,-3.5,46.53,1.0,2.0,4.0,2.0,3.96,-3.7
Lutein,C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,8.0,3.0,12.0,5.09,568.886,8.55,-5.9,40.46,2.0,2.0,10.0,2.0,18.22,-0.91
Codeine,[H][C@]12C=C[C@H](O)[C@@H]3OC4=C5C(C[C@H]1N(C)CC[C@@]235)=CC=C4OC,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,2.5,7.15,2.99,299.3642,1.34,-2.7,41.93,1.0,4.0,1.0,5.0,13.78,9.19
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,1.5,4.67,1.94,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Linezolid,CC(=O)NC[C@H]1CN(C(=O)O1)C1=CC(F)=C(C=C1)N1CCOCC1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.96,1.24,337.3461,0.64,-2.4,71.11,1.0,5.0,4.0,3.0,14.85,-1.2
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,7.0,3.5,6.76,2.82,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Digoxin,[H][C@]12CC[C@]3([H])[C@]([H])(C[C@@H](O)[C@]4(C)[C@H](CC[C@]34O)C3=CC(=O)OC3)[C@@]1(C)CC[C@@H](C2)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,2.5,7.66,3.21,780.9385,2.37,-3.8,203.06,6.0,13.0,7.0,8.0,7.15,-3.0
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,9.0,4.5,11.92,5.05,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Oxaliplatin,[H][N]1([H])[C@@H]2CCCC[C@H]2[N]([H])([H])[Pt]11OC(=O)C(=O)O1,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,10.0,3.5,8.88,3.69,397.294,-0.47,-1.2,85.82,0.0,0.0,0.0,3.0,,
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,acid_hydrolysis,HCl,moderate,mid,medium,low,40.0,4.5,0.03,1.75,100.0,0.0,6.0,3.0,5.05,2.09,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Nitric Oxide,[N]=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,15.98,6.81,30.0061,-0.35,,34.14,0.0,1.0,0.0,0.0,,-2.9
Timolol,[H][C@](O)(CNC(C)(C)C)COC1=NSN=C1N1CCOCC1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,3.0,7.37,3.08,316.42,1.34,-3.1,79.74,2.0,7.0,7.0,2.0,14.08,9.76
Loracarbef,N[C@@H](C(=O)N[C@H]1[C@H]2CCC(Cl)=C(N2C1=O)C(O)=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.0,7.06,2.95,349.769,-2.4,-3.0,112.73,3.0,5.0,4.0,3.0,2.93,7.23
Cystine,N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,4.0,1.0,7.57,3.16,240.3,-5.9,-1.2,126.64,4.0,6.0,7.0,0.0,1.56,9.34
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.21,1.75,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.5,5.41,2.24,418.4403,2.54,-4.5,117.0,1.0,6.0,10.0,2.0,16.96,-4.1
Pyrazinamide,NC(=O)C1=NC=CN=C1,acid_hydrolysis,HCl,mild,low,medium,low,25.0,6.0,0.01,2.0,100.0,0.0,1.5,0.5,2.02,0.85,123.1127,-1.2,-0.12,68.87,1.0,3.0,1.0,1.0,13.06,-0.55
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.04,1.27,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,1.5,3.11,1.29,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.5,2.7,5.09,2.11,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Fluvoxamine,COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,6.26,2.6,318.34,2.8,-4.6,56.84,1.0,4.0,10.0,1.0,,8.86
Oxytetracycline,[H][C@@]12[C@@H](O)[C@@]3([H])C(C(=O)C4=C(C=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,7.0,2.5,6.29,2.62,460.434,-4.5,-2.5,201.85,7.0,10.0,2.0,4.0,2.84,7.41
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,8.0,3.0,6.99,2.91,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Sulfadiazine,NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CC=N1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,10.0,4.0,8.0,3.34,250.277,0.39,-2.6,97.97,2.0,5.0,2.0,2.0,6.99,2.01
Cyproheptadine,CN1CCC(CC1)=C1C2=CC=CC=C2C=CC2=CC=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.5,5.12,2.13,287.3981,4.38,-4.3,3.24,0.0,1.0,0.0,4.0,,8.05
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.0,5.66,2.35,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Adenosine phosphate,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,3.0,1.0,4.65,1.93,347.2212,-4.7,,186.07,5.0,10.0,4.0,3.0,1.23,3.92
Valsartan,CCCCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NNN=N1)[C@@H](C(C)C)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,7.0,3.5,6.98,2.91,435.5188,5.27,-4.3,112.07,2.0,6.0,10.0,3.0,4.35,-0.64
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,3.0,7.22,3.02,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.32,0.98,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.0,4.59,1.9,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=C1,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.5,2.3,5.49,2.26,355.861,3.8,-4.6,48.39,2.0,4.0,6.0,3.0,9.1,10.17
Duloxetine,CNCC[C@H](OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,0.5,2.35,0.95,297.415,4.2,-5.0,21.26,1.0,2.0,6.0,3.0,,9.7
Flunisolide,[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4([H])[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)CO,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,1.0,3.69,1.53,434.4977,1.56,-4.1,93.06,2.0,6.0,2.0,5.0,13.73,-2.9
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,4.0,2.0,4.55,1.88,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.0,4.57,1.86,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,4.0,7.78,3.26,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Fluorouracil,FC1=CNC(=O)NC1=O,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.5,13.65,5.82,130.0772,-0.66,-1.4,58.2,2.0,2.0,0.0,1.0,7.18,-8.0
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,15.0,7.0,11.72,4.97,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Asparagine,N[C@@H](CC(N)=O)C(O)=O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,3.0,1.0,3.76,1.56,132.1179,-4.3,0.1,106.41,3.0,4.0,3.0,0.0,2.0,8.43
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,5.0,2.0,4.5,1.87,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,1.0,0.5,2.47,1.04,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,3.5,7.38,3.09,339.4745,3.47,-3.8,59.22,1.0,3.0,8.0,2.0,16.19,10.42
Methyclothiazide,CN1C(CCl)NC2=CC(Cl)=C(C=C2S1(=O)=O)S(N)(=O)=O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,5.0,2.0,6.51,2.71,360.237,0.53,-2.6,109.57,2.0,5.0,2.0,2.0,9.29,-3.4
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,9.0,4.0,8.98,3.77,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,17.0,8.0,12.36,5.25,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Droperidol,FC1=CC=C(C=C1)C(=O)CCCN1CCC(=CC1)N1C(=O)NC2=CC=CC=C12,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.03,0.86,379.4274,3.01,-3.6,52.65,1.0,3.0,6.0,4.0,12.72,6.75
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,2.5,5.7,2.36,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Darifenacin,NC(=O)C([C@@H]1CCN(CCC2=CC3=C(OCC3)C=C2)C1)(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,3.5,7.32,3.07,426.55,4.54,-6.2,55.56,1.0,3.0,7.0,5.0,16.21,10.11
Nabilone,[H][C@@]12CC(=O)CC[C@@]1([H])C(C)(C)OC1=CC(=CC(O)=C21)C(C)(C)CCCCCC,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,3.41,1.42,372.5408,6.36,-5.9,46.53,1.0,3.0,6.0,3.0,9.33,-4.9
Sulpiride,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,5.0,2.0,5.67,2.36,341.426,0.22,-2.8,101.73,2.0,5.0,6.0,2.0,10.24,8.39
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,17.0,7.0,13.43,5.7,318.864,4.54,-4.9,6.48,0.0,2.0,4.0,3.0,,9.2
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,3.0,5.13,2.12,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Pentagastrin,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=C1C=CC=C2)NC(=O)CCNC(=O)OC(C)(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,4.0,7.31,3.05,767.9,1.05,-5.5,250.91,8.0,8.0,22.0,3.0,4.0,
Fosinopril,CCC(=O)O[C@@H](OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1C[C@@H](C[C@H]1C(O)=O)C1CCCCC1)C(C)C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,8.0,3.5,7.33,3.06,563.672,5.62,-5.8,110.21,1.0,5.0,15.0,3.0,3.87,-4.4
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,3.0,5.23,2.17,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Mephenytoin,CCC1(NC(=O)N(C)C1=O)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,6.0,2.0,5.33,2.21,218.2518,1.67,-2.4,49.41,1.0,2.0,2.0,2.0,11.09,-8.1
Esmolol,COC(=O)CCC1=CC=C(OCC(O)CNC(C)C)C=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,8.0,14.06,5.98,295.374,1.82,-3.3,67.79,2.0,4.0,10.0,1.0,14.09,9.67
Trospium,[H][C@]12CC[C@]([H])(C[C@@H](C1)OC(=O)C(O)(C1=CC=CC=C1)C1=CC=CC=C1)[N+]21CCCC1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,5.0,8.9,3.73,392.518,-0.5,-6.8,46.53,1.0,2.0,5.0,5.0,11.05,-4.5
Ethambutol,CC[C@@H](CO)NCCN[C@@H](CC)CO,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,8.0,4.0,8.85,3.72,204.3098,-0.059,,64.52,4.0,4.0,9.0,0.0,14.82,9.55
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,4.0,1.5,5.78,2.4,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.92,1.22,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Metolazone,CC1NC2=CC(Cl)=C(C=C2C(=O)N1C1=CC=CC=C1C)S(N)(=O)=O,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,3.0,5.89,2.44,365.835,2.94,-4.0,92.5,2.0,4.0,2.0,3.0,9.54,-1.6
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,3.0,1.0,4.55,1.83,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,17.0,8.5,12.33,5.24,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Vitamin A,C\C(=C/CO)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,6.0,1.5,6.13,2.55,286.4516,4.69,-4.6,20.23,1.0,1.0,5.0,1.0,16.44,-2.2
Bendroflumethiazide,NS(=O)(=O)C1=CC2=C(NC(CC3=CC=CC=C3)NS2(=O)=O)C=C1C(F)(F)F,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,5.0,15.84,6.75,421.415,1.7,-3.3,118.36,3.0,5.0,4.0,3.0,9.04,-3.1
Sucralfate,O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@](COS(=O)(=O)O[Al](O)O)(O[C@H]2O[C@H](COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@H]2OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,4.0,1.5,2.97,1.24,1558.67,-5.9,-3.3,772.17,16.0,35.0,37.0,2.0,13.53,-3.0
Loratadine,CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,3.0,1.0,2.24,0.94,382.883,4.55,-4.5,42.43,0.0,2.0,2.0,4.0,,4.33
Beclomethasone dipropionate,[H][C@@]12C[C@H](C)[C@](OC(=O)CC)(C(=O)COC(=O)CC)[C@@]1(C)C[C@H](O)[C@@]1(Cl)[C@@]2([H])CCC2=CC(=O)C=C[C@]12C,base_hydrolysis,NaOH,strong,high,short,medium,60.0,1.0,0.1,13.0,100.0,0.0,13.0,6.5,11.99,5.08,521.042,4.43,-5.4,106.97,1.0,5.0,8.0,4.0,13.85,-3.3
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,8.0,3.0,4.57,1.9,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.0,3.41,1.42,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Oseltamivir,CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,2.97,1.24,312.4045,1.16,-2.7,90.65,2.0,4.0,8.0,1.0,14.03,9.31
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,12.0,6.0,14.56,6.2,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Nicotine,CN1CCC[C@H]1C1=CN=CC=C1,base_hydrolysis,NaOH,strong,high,short,high,60.0,0.5,1.0,14.0,100.0,0.0,15.0,7.0,15.12,6.46,162.2316,1.16,-0.24,16.13,0.0,2.0,1.0,2.0,,8.58
Vidarabine,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,7.0,3.0,7.63,3.2,267.2413,-2.1,-1.3,139.54,4.0,8.0,2.0,3.0,12.45,3.94
Ascorbic acid,[H][C@@]1(OC(=O)C(O)=C1O)[C@@H](O)CO,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,4.0,2.0,7.83,3.27,176.1241,-1.9,0.14,107.22,4.0,5.0,2.0,1.0,4.16,-3.0
Nitisinone,[O-][N+](=O)C1=C(C=CC(=C1)C(F)(F)F)C(=O)C1C(=O)CCCC1=O,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,10.0,4.0,7.78,3.25,329.2281,3.13,-4.6,94.35,0.0,5.0,4.0,2.0,7.44,-7.3
Vitamin E,CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCC2=C(O1)C(C)=C(C)C(O)=C2C,base_hydrolysis,NaOH,moderate,high,short,low,60.0,1.0,0.01,12.0,100.0,0.0,2.0,0.7,3.77,1.5,430.7061,10.51,-7.8,29.46,1.0,2.0,12.0,2.0,10.8,-4.9
Lysine,NCCCC[C@H](N)C(O)=O,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.0,5.67,2.36,146.1876,-3.2,-0.14,89.34,3.0,4.0,5.0,0.0,2.74,10.29
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,5.0,2.0,5.23,2.17,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Lymecycline,[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(O)C=CC=C4[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(=O)NCNCCCC[C@H](N)C(O)=O)=C(O)[C@H]2N(C)C,base_hydrolysis,NaOH,mild,low,medium,low,25.0,6.0,0.01,12.0,100.0,0.0,4.0,1.5,2.39,1.01,602.6328,-7.1,-2.7,242.98,9.0,13.0,10.0,4.0,2.51,9.77
Oxiconazole,ClC1=CC(Cl)=C(CO\N=C(/CN2C=CN=C2)C2=CC=C(Cl)C=C2Cl)C=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,3.0,1.0,4.39,1.78,429.12,5.84,-5.4,39.41,0.0,3.0,6.0,3.0,,6.74
Ramipril,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,base_hydrolysis,NaOH,mild,low,medium,high,25.0,2.0,1.0,14.0,100.0,0.0,4.0,1.5,4.6,1.91,416.5106,1.47,-4.0,95.94,2.0,5.0,10.0,3.0,3.75,5.2
Ceftazidime,[O-]C(=O)C1=C(CS[C@]2([H])[C@H](NC(=O)C(=N/OC(C)(C)C(O)=O)\C3=CSC(N)=N3)C(=O)N12)C[N+]1=CC=CC=C1,base_hydrolysis,NaOH,strong,high,medium,medium,60.0,2.0,0.1,13.0,100.0,0.0,10.0,4.0,11.73,4.97,546.576,-4.2,-5.0,191.22,3.0,10.0,9.0,4.0,2.42,4.02
Acetyldigitoxin,[H][C@@]1(CC[C@]2(O)[C@]3([H])CC[C@]4([H])C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(C)=O)[C@H](O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1)C1=CC(=O)OC1,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,4.0,2.0,3.38,1.41,806.9757,4.04,-4.8,188.9,4.0,12.0,9.0,8.0,7.18,0.24
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,6.5,2.8,5.69,2.33,318.864,4.54,-4.9,6.48,0.0,2.0,4.0,3.0,,9.2
Gadodiamide,[Gd+3].CNC(=O)CN(CCN(CCN(CC([O-])=O)CC(=O)NC)CC([O-])=O)CC([O-])=O,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,3.0,1.0,5.27,2.18,573.66,-8.7,-2.1,188.31,2.0,11.0,16.0,0.0,1.02,8.34
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,acid_hydrolysis,HCl,moderate,mid,medium,medium,40.0,6.0,0.1,1.2,100.0,0.0,9.0,4.0,7.11,2.97,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,4.0,2.0,3.2,1.32,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Cefdinir,[H][C@]12SCC(C=C)=C(N1C(=O)[C@H]2NC(=O)C(=N/O)\C1=CSC(N)=N1)C(O)=O,acid_hydrolysis,HCl,moderate,high,medium,medium,60.0,4.0,0.1,1.2,100.0,0.0,8.0,3.0,7.05,2.94,395.414,-0.89,-3.6,158.21,4.0,8.0,5.0,3.0,2.73,3.61
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.5,3.0,1.25,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Baclofen,NCC(CC(O)=O)C1=CC=C(Cl)C=C1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.5,5.55,2.3,213.661,-0.78,-2.5,63.32,2.0,3.0,4.0,1.0,3.89,9.79
Lercanidipine,COC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)(C)CN(C)CCC(C1=CC=CC=C1)C1=CC=CC=C1,acid_hydrolysis,HCl,moderate,high,short,low,60.0,1.0,0.01,2.0,100.0,0.0,4.0,1.0,5.31,2.2,611.7272,6.41,-6.6,111.01,1.0,6.0,14.0,4.0,16.96,9.36
Secobarbital,CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O,base_hydrolysis,NaOH,moderate,mid,short,high,40.0,1.0,1.0,14.0,100.0,0.0,9.0,3.0,8.73,3.66,238.2829,2.03,-2.3,75.27,2.0,3.0,5.0,1.0,7.48,
Ethionamide,CCC1=NC=CC(=C1)C(N)=S,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,1.5,5.99,2.46,166.243,1.33,-2.3,38.91,1.0,1.0,2.0,1.0,11.89,5.0
Montelukast,OC(=O)CC1(CC1)CS[C@H](CCC1=CC=CC=C1C(O)(C)C)C1=CC=CC(\C=C\C2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,10.0,5.0,12.52,5.31,586.183,8.49,-7.8,70.42,2.0,4.0,12.0,5.0,4.4,3.12
Atomoxetine,CNCC[C@@H](OC1=CC=CC=C1C)C1=CC=CC=C1,base_hydrolysis,NaOH,moderate,mid,medium,medium,40.0,6.0,0.1,13.0,100.0,0.0,5.0,2.5,6.68,2.8,255.3547,3.81,-4.8,21.26,1.0,2.0,6.0,2.0,,9.8
Calcifediol,C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,2.0,1.0,2.44,1.01,400.6371,5.65,-5.3,40.46,2.0,2.0,6.0,3.0,18.38,-0.98
Fondaparinux,CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O,base_hydrolysis,NaOH,mild,low,medium,medium,25.0,13.0,0.3,13.25,100.0,0.0,3.0,1.5,3.53,1.47,1508.263,-10.0,-2.3,805.48,19.0,44.0,27.0,5.0,-3.0,
Cevimeline,CC1O[C@@]2(CS1)CN1CCC2CC1,acid_hydrolysis,HCl,moderate,mid,short,high,40.0,1.0,1.0,0.5,100.0,0.0,8.0,3.0,8.07,3.37,199.313,1.0,-1.9,12.47,0.0,2.0,0.0,3.0,,8.59
Zanamivir,[H][C@]1(OC(=C[C@H](N=C(N)N)[C@H]1NC(C)=O)C(O)=O)[C@H](O)[C@H](O)CO,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,16.0,5.0,14.18,6.03,332.3098,-5.8,-1.7,200.72,7.0,10.0,6.0,1.0,3.06,11.93
Pimecrolimus,[H][C@]1(CC[C@H](Cl)[C@@H](C1)OC)\C=C(/C)[C@@]1([H])OC(=O)[C@]2([H])CCCCN2C(=O)C(=O)[C@]2(O)O[C@@]([H])([C@H](C[C@H]2C)OC)[C@H](C[C@@H](C)C\C(C)=C\[C@@H](CC)C(=O)C[C@H](O)[C@H]1C)OC,acid_hydrolysis,HCl,mild,low,medium,medium,25.0,13.0,0.3,1.0,100.0,0.0,3.0,1.0,2.88,1.21,810.46,6.81,-5.7,158.13,2.0,10.0,6.0,4.0,9.96,-2.9
Remikiren,CC(C)(C)S(=O)(=O)C[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C1CC1,base_hydrolysis,NaOH,moderate,mid,medium,low,40.0,4.5,0.03,12.25,100.0,0.0,7.0,3.5,5.56,2.31,630.838,2.37,-4.5,161.48,5.0,7.0,16.0,4.0,12.32,6.74
Dihydroergotamine,[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)[C@@]4([H])C3)O[C@@]21O,acid_hydrolysis,HCl,mild,low,medium,high,25.0,2.0,1.0,0.5,100.0,0.0,5.0,2.0,3.63,1.51,583.6774,2.71,-3.4,118.21,3.0,6.0,4.0,8.0,9.71,8.39
alpha-Linolenic acid,CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O,acid_hydrolysis,HCl,strong,high,short,high,60.0,0.5,1.0,0.5,100.0,0.0,12.0,4.0,13.3,5.66,278.4296,6.06,-6.0,37.3,1.0,2.0,13.0,0.0,4.99,
